Literature DB >> 29293097

Resolution of organ fibrosis.

Joon-Il Jun, Lester F Lau.   

Abstract

Fibrosis is the excessive accumulation of extracellular matrix that often occurs as a wound healing response to repeated or chronic tissue injury, and may lead to the disruption of organ architecture and loss of function. Although fibrosis was previously thought to be irreversible, recent evidence indicates that certain circumstances permit the resolution of fibrosis when the underlying causes of injury are eradicated. The mechanism of fibrosis resolution encompasses degradation of the fibrotic extracellular matrix as well as elimination of fibrogenic myofibroblasts through their adaptation of various cell fates, including apoptosis, senescence, dedifferentiation, and reprogramming. In this Review, we discuss the present knowledge and gaps in our understanding of how matrix degradation is regulated and how myofibroblast cell fates can be manipulated, areas that may identify potential therapeutic approaches for fibrosis.

Entities:  

Mesh:

Year:  2018        PMID: 29293097      PMCID: PMC5749507          DOI: 10.1172/JCI93563

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  180 in total

1.  Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis.

Authors:  Paul Flechsig; Bettina Hartenstein; Sybille Teurich; Monika Dadrich; Kai Hauser; Amir Abdollahi; Hermann-Josef Gröne; Peter Angel; Peter E Huber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-01       Impact factor: 7.038

2.  Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.

Authors:  Banu A Karimi-Shah; Badrul A Chowdhury
Journal:  N Engl J Med       Date:  2015-03-26       Impact factor: 91.245

3.  Identification of a factor that links apoptotic cells to phagocytes.

Authors:  Rikinari Hanayama; Masato Tanaka; Keiko Miwa; Azusa Shinohara; Akihiro Iwamatsu; Shigekazu Nagata
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

4.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

5.  Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis.

Authors:  Sebastian Szardien; Holger M Nef; Sandra Voss; Christian Troidl; Christoph Liebetrau; Jedrzej Hoffmann; Maximilian Rauch; Katharina Mayer; Kathrin Kimmich; Andreas Rolf; Johannes Rixe; Kerstin Troidl; Baktybek Kojonazarov; Ralph T Schermuly; Sawa Kostin; Albrecht Elsässer; Christian W Hamm; Helge Möllmann
Journal:  Eur Heart J       Date:  2011-11-21       Impact factor: 29.983

6.  Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells.

Authors:  Shunsuke Minagawa; Jun Araya; Takanori Numata; Satoko Nojiri; Hiromichi Hara; Yoko Yumino; Makoto Kawaishi; Makoto Odaka; Toshiaki Morikawa; Stephen L Nishimura; Katsutoshi Nakayama; Kazuyoshi Kuwano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-17       Impact factor: 5.464

7.  Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis.

Authors:  Chi Hung; Geoffrey Linn; Yu-Hua Chow; Akio Kobayashi; Kristen Mittelsteadt; William A Altemeier; Sina A Gharib; Lynn M Schnapp; Jeremy S Duffield
Journal:  Am J Respir Crit Care Med       Date:  2013-10-01       Impact factor: 21.405

Review 8.  The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair.

Authors:  Brian M Stramer; Ryoichi Mori; Paul Martin
Journal:  J Invest Dermatol       Date:  2007-05       Impact factor: 8.551

9.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.

Authors:  Naoki Ikenaga; Zhen-Wei Peng; Kahini A Vaid; Susan B Liu; Shuhei Yoshida; Deanna Y Sverdlov; Amanda Mikels-Vigdal; Victoria Smith; Detlef Schuppan; Yury V Popov
Journal:  Gut       Date:  2017-01-10       Impact factor: 23.059

View more
  87 in total

Review 1.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

Review 3.  You Say You Want a Resolution (of Fibrosis).

Authors:  Kamran Atabai; Christopher D Yang; Michael J Podolsky
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 4.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 5.  The matricellular protein CCN1 in tissue injury repair.

Authors:  Ki-Hyun Kim; Jong Hoon Won; Naiyuan Cheng; Lester F Lau
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

6.  Expression Profiling of Fibroblasts in Chronic and Acute Disease Models Reveals Novel Pathways in Kidney Fibrosis.

Authors:  Atsuko Y Higashi; Bruce J Aronow; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2018-12-13       Impact factor: 10.121

Review 7.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01

Review 8.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

Review 9.  Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

Authors:  Brahim Chaqour
Journal:  J Cell Commun Signal       Date:  2019-08-02       Impact factor: 5.782

10.  Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury.

Authors:  Yuan Gui; Qingmiao Lu; Mengru Gu; Mingjie Wang; Yan Liang; Xingwen Zhu; Xian Xue; Xiaoli Sun; Weichun He; Junwei Yang; Allan Zijian Zhao; Bo Xiao; Chunsun Dai
Journal:  Cell Death Differ       Date:  2019-04-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.